WO2008111020A3 - Macrolide derivatives as antibacterial agents - Google Patents
Macrolide derivatives as antibacterial agents Download PDFInfo
- Publication number
- WO2008111020A3 WO2008111020A3 PCT/IB2008/050979 IB2008050979W WO2008111020A3 WO 2008111020 A3 WO2008111020 A3 WO 2008111020A3 IB 2008050979 W IB2008050979 W IB 2008050979W WO 2008111020 A3 WO2008111020 A3 WO 2008111020A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds disclosed
- antibacterial agents
- spp
- macrolide derivatives
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
The present invention provides macrolide derivatives, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed to by gram positive, gram negative or anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Moraxalla spp., Chlamydia spp., Mycoplasm, Legionella spp., Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Bacillus, Enterobactericeae or any combination thereof. Also provided, are the processes for preparing the compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN551DE2007 | 2007-03-14 | ||
IN551/DEL/2007 | 2007-03-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008111020A2 WO2008111020A2 (en) | 2008-09-18 |
WO2008111020A3 true WO2008111020A3 (en) | 2008-11-13 |
Family
ID=39730790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/050979 WO2008111020A2 (en) | 2007-03-14 | 2008-03-14 | Macrolide derivatives as antibacterial agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008111020A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104610402A (en) * | 2014-12-30 | 2015-05-13 | 晋江市托美汀生物科技有限公司 | Preparation method of macrolide impurity |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104558069B (en) * | 2014-12-31 | 2017-01-04 | 广东东阳光药业有限公司 | The synthetic method of macrolide impurity |
CN108727445B (en) * | 2018-06-29 | 2021-06-11 | 宜昌东阳光生化制药有限公司 | Synthesis method of azithromycin impurity F |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999016779A1 (en) * | 1997-09-30 | 1999-04-08 | Abbott Laboratories | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
WO2000012521A1 (en) * | 1998-08-26 | 2000-03-09 | Abbott Laboratories | 3', 3'-n-bis-desmethyl-3'-n-cycloalkyl erythromycin derivatives as lhrh antagonists |
WO2007129646A1 (en) * | 2006-05-01 | 2007-11-15 | Taisho Pharmaceutical Co., Ltd. | Macrolide derivative |
-
2008
- 2008-03-14 WO PCT/IB2008/050979 patent/WO2008111020A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999016779A1 (en) * | 1997-09-30 | 1999-04-08 | Abbott Laboratories | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
WO2000012521A1 (en) * | 1998-08-26 | 2000-03-09 | Abbott Laboratories | 3', 3'-n-bis-desmethyl-3'-n-cycloalkyl erythromycin derivatives as lhrh antagonists |
WO2007129646A1 (en) * | 2006-05-01 | 2007-11-15 | Taisho Pharmaceutical Co., Ltd. | Macrolide derivative |
Non-Patent Citations (1)
Title |
---|
"The Merck Index", 2001, MERCK & CO., WHITEHOUSE STATION, NJ, XP002495203 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104610402A (en) * | 2014-12-30 | 2015-05-13 | 晋江市托美汀生物科技有限公司 | Preparation method of macrolide impurity |
CN104610402B (en) * | 2014-12-30 | 2017-01-25 | 晋江市托美汀生物科技有限公司 | Preparation method of macrolide impurity |
Also Published As
Publication number | Publication date |
---|---|
WO2008111020A2 (en) | 2008-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513903A (en) | ketolide derivatives useful as antimicrobial agents, their preparation processes and pharmaceutical compositions comprising the same | |
WO2007060518A3 (en) | Ketolide derivatives as antibacterial agents | |
WO2006046112A3 (en) | Ketolide derivatives as antibacterial agents | |
WO2010013222A8 (en) | Pyrrole carboxylic acid derivatives as antibacterial agents | |
WO2006117762A8 (en) | Antimicrobial agents | |
MX348083B (en) | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof. | |
WO2007136719A3 (en) | Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof | |
WO2010063996A3 (en) | Antibacterial compounds | |
NZ591051A (en) | C7-fluoro substituted tetracycline compounds | |
MX347688B (en) | Boron-containing small molecules. | |
TW200734344A (en) | Antibacterial agents | |
WO2007116322A3 (en) | Purification of bacterial antigens | |
WO2006120563A3 (en) | Antibacterial agents | |
WO2011019839A3 (en) | Glycopeptide and lipoglycopeptide antibiotics with improved solubility | |
WO2009085277A3 (en) | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars | |
WO2009042270A3 (en) | Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity | |
WO2008111020A3 (en) | Macrolide derivatives as antibacterial agents | |
MX2011011190A (en) | Methods of treating a pulmonary bacterial infection using fluoro-quinolones. | |
NZ584159A (en) | 6,11-bridged biaryl macrolides | |
WO2007089612A3 (en) | Methods and compositions for treating and preventing bacterial infections | |
WO2007060618A3 (en) | Macrolides derivatives as antibacterial agents | |
MXPA05009688A (en) | Naphthyridine derivatives as antibacterial agents. | |
MX2012001065A (en) | Media for the specific detection of gram-negative bacteria resistant to beta-lactam antibiotics. | |
WO2008110918A3 (en) | Erythromycin-based macrolides | |
WO2009073534A3 (en) | Bicyclic ppat inhibitors as antibacterial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08719715 Country of ref document: EP Kind code of ref document: A2 |